首页> 外文OA文献 >Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia

【2h】

Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia

机译：日本针对精神分裂症的有用药物计划（JUMP）-精神分裂症患者非典型抗精神病药物的停药率，缓解和缓解以及社会功能改善的长期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia [J] . Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, BMC Psychiatry . 2013,第1期

机译：日本对精神分裂症有用的药物计划（JUMPs）-精神分裂症患者非典型抗精神病药物的停药率，缓解和缓解以及社会功能改善的长期研究
2. TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial [J] . Anne Emilie Stürup, Heidi Dorthe Jensen, Signe Dolmer, Trials . 2017,第1期

机译：TAILOR –新诊断为精神分裂症或持续性妄想障碍缓解精神病症状的患者中抗精神病药物的锥形停药与维持治疗：一项随机临床试验的研究方案
3. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission. [J] . Yen CF, Cheng CP, Huang CF, Bipolar disorders. . 2008,第5期

机译：躁郁症和精神分裂症缓解期患者的生活质量及其与洞察力，药物不良反应和使用非典型抗精神病药的关联。
4. Antipsychotic medication influences cardiovascular coupling in patients suffering from acute schizophrenia [C] . Schulz Steffen, Haueisen Jens, Bar Karl-Jurgen, Computing in Cardiology Conference . 2014

机译：抗精神病药会影响急性精神分裂症患者的心血管耦合
5. Effects of a formulary expansion on the use of atypical antipsychotics and health care services by patients with schizophrenia in the California Medicaid Program. [D] . Mulani, Parvez. 2009

机译：在加利福尼亚医疗补助计划中，处方药扩展对精神分裂症患者使用非典型抗精神病药和保健服务的影响。
6. Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate resolution and remission and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia [O] . Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, 2013

机译：日本针对精神分裂症的有用药物计划（JUMP）-精神分裂症患者非典型抗精神病药物的停药率缓解和缓解以及社会功能改善的长期研究
7. PMH22 HOSPITALIZATION AND MEDICATION USE IN SCHIZOPHRENIA PATIENTS RECEIVING RISPERIDONE LONG-ACTING INJECTABLE OR ORAL ATYPICAL ANTIPSYCHOTIC MEDICATION [O] . Chue P, Lam A, Chandra K, 2005

机译：接受利培酮长效注射或口服非典型抗精神病药的精神分裂症患者的PMH22住院治疗和药物使用

Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia

著录项

引文网络

相似文献

相关主题

期刊订阅